Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 20MG/ML
USFDA APPLICATION NUMBER - 11757
DOSAGE - INJECTABLE;INJECTION - 40MG/ML
USFDA APPLICATION NUMBER - 11757
DOSAGE - INJECTABLE;INJECTION - 80MG/ML
USFDA APPLICATION NUMBER - 11757
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Topical
Emulsifying Agents
Film Formers & Plasticizers
Surfactant & Foaming Agents
Thickeners and Stabilizers
Co-Processed Excipients
Direct Compression
Rheology Modifiers
API Stability Enhancers
Lubricants & Glidants
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
25
PharmaCompass offers a list of Methylprednisolone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylprednisolone Acetate manufacturer or Methylprednisolone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylprednisolone Acetate manufacturer or Methylprednisolone Acetate supplier.
PharmaCompass also assists you with knowing the Methylprednisolone Acetate API Price utilized in the formulation of products. Methylprednisolone Acetate API Price is not always fixed or binding as the Methylprednisolone Acetate Price is obtained through a variety of data sources. The Methylprednisolone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Depo Medrol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Depo Medrol, including repackagers and relabelers. The FDA regulates Depo Medrol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Depo Medrol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Depo Medrol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Depo Medrol supplier is an individual or a company that provides Depo Medrol active pharmaceutical ingredient (API) or Depo Medrol finished formulations upon request. The Depo Medrol suppliers may include Depo Medrol API manufacturers, exporters, distributors and traders.
click here to find a list of Depo Medrol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Depo Medrol DMF (Drug Master File) is a document detailing the whole manufacturing process of Depo Medrol active pharmaceutical ingredient (API) in detail. Different forms of Depo Medrol DMFs exist exist since differing nations have different regulations, such as Depo Medrol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Depo Medrol DMF submitted to regulatory agencies in the US is known as a USDMF. Depo Medrol USDMF includes data on Depo Medrol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Depo Medrol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Depo Medrol suppliers with USDMF on PharmaCompass.
A Depo Medrol CEP of the European Pharmacopoeia monograph is often referred to as a Depo Medrol Certificate of Suitability (COS). The purpose of a Depo Medrol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Depo Medrol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Depo Medrol to their clients by showing that a Depo Medrol CEP has been issued for it. The manufacturer submits a Depo Medrol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Depo Medrol CEP holder for the record. Additionally, the data presented in the Depo Medrol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Depo Medrol DMF.
A Depo Medrol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Depo Medrol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Depo Medrol suppliers with CEP (COS) on PharmaCompass.
A Depo Medrol written confirmation (Depo Medrol WC) is an official document issued by a regulatory agency to a Depo Medrol manufacturer, verifying that the manufacturing facility of a Depo Medrol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Depo Medrol APIs or Depo Medrol finished pharmaceutical products to another nation, regulatory agencies frequently require a Depo Medrol WC (written confirmation) as part of the regulatory process.
click here to find a list of Depo Medrol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Depo Medrol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Depo Medrol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Depo Medrol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Depo Medrol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Depo Medrol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Depo Medrol suppliers with NDC on PharmaCompass.
Depo Medrol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Depo Medrol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Depo Medrol GMP manufacturer or Depo Medrol GMP API supplier for your needs.
A Depo Medrol CoA (Certificate of Analysis) is a formal document that attests to Depo Medrol's compliance with Depo Medrol specifications and serves as a tool for batch-level quality control.
Depo Medrol CoA mostly includes findings from lab analyses of a specific batch. For each Depo Medrol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Depo Medrol may be tested according to a variety of international standards, such as European Pharmacopoeia (Depo Medrol EP), Depo Medrol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Depo Medrol USP).
